Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial
BRACE
1 other identifier
interventional
96
1 country
1
Brief Summary
Several attempts have been made to reduce these failure rates and improve return to sports rates in high-risk populations, and one of these approaches has been postoperative bracing. A recent survey of the Anterior cruciate ligament (ACL) Study Group has shown that 53% of surgeons prefers functional bracing following ACL reconstruction. Currently, however, there is no clear consensus on whether functional bracing following ACL reconstruction leads to lower failure rates, improved stability or better patient-reported outcomes when compared to ACL reconstruction without bracing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2025
CompletedFirst Posted
Study publicly available on registry
April 24, 2025
CompletedStudy Start
First participant enrolled
September 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
April 1, 2026
March 1, 2026
2.7 years
April 16, 2025
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in ACL-return to sport index (ACL-RSI) Scores
The ACL-Return to Sport after Injury scale (ACL-RSI) is a 12-item survey that measures psychological readiness to return to sport after an ACL injury or surgery. It uses a visual analog scale from 0 to 100, where higher scores indicate greater psychological readiness. The total score is calculated as a percentage of the 12-item total score. A higher ACL-RSI score indicates a greater level of psychological readiness for returning to sport.
Baseline and 3, 6, 12, and 24 months
Secondary Outcomes (20)
Tampa Scale Kinesiophobia 11 (TSK-11) Score
Baseline and 3, 6, 12, and 24 months
International Knee Documentation Committee (IKDC) Score
Baseline and 3, 6, 12, and 24 months
Lysholm score
Baseline and 3, 6, 12, and 24 months
Forgotten Joint Score (FJS-12)
Baseline and 3, 6, 12, and 24 months
SANE Score
Baseline and 3, 6, 12, and 24 months
- +15 more secondary outcomes
Study Arms (2)
With postoperative brace (DonJoy Defiance Pro)
EXPERIMENTALQuadriceps Autograft ACL Reconstruction with the use of post-surgical functional bracing, using the DonJoy Defiance Pro brace
Without post-surgical functional bracing
NO INTERVENTIONQuadriceps Autograft ACL Reconstruction without the use of post-surgical functional bracing
Interventions
Quadriceps Autograft ACL Reconstruction with the use of post-surgical functional bracing, using the DonJoy Defiance Pro brace
Eligibility Criteria
You may qualify if:
- patients with unilateral complete ACL injury
- patients involved in sports and the desire to return to sports
- patients undergoing quadriceps autograft ACL reconstruction
- must be 14 to 39 years old
You may not qualify if:
- multiligamentous knee injuries defined as two ligaments requiring surgical stabilization
- concomitant suture tape augmentation, extra-articular tenodesis or anterolateral ligament reconstruction
- concomitant femoral, tibial, or patellar fracture(s)
- patients with significant osteoarthritis
- concomitant ipsilateral knee dislocation or patellar dislocation
- significant lower leg malalignment requiring correcting osteotomies
- prior ACL surgery, including contralateral knee
- pregnancy during injury or surgery
- unable to provide consent
- prolonged use of prednisolone or cytostatics
- comorbidities (e.g., muscular, neurological, vascular) that influence rehabilitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Waterman, MD
Wake Forest University Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2025
First Posted
April 24, 2025
Study Start
September 11, 2025
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share